TELA Bio (TELA) Total Liabilities (2018 - 2026)

TELA Bio has reported Total Liabilities for 9 years, with the latest figure at $75.1 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities rose 27.0% year-over-year to $75.1 million; the trailing twelve-month figure through Mar 2026 stood at $75.1 million (up 27.0% YoY), and the FY2025 full-year result was $75.1 million, up 29.24% from the prior year.
• Total Liabilities for Q1 2026 stood at $75.1 million, roughly flat from $75.1 million in the prior quarter.
• The five-year high for Total Liabilities was $75.1 million in Q4 2025, with the low at $45.3 million in Q1 2022.
• Average Total Liabilities over 5 years is $58.5 million, with a median of $57.5 million recorded in 2024.
• Year-over-year, Total Liabilities jumped 36.96% in 2022 and declined 1.78% in 2024.
• Tracing TELA's Total Liabilities over 5 years: stood at $53.6 million in 2022, then gained by 10.49% to $59.2 million in 2023, then dropped by 1.78% to $58.1 million in 2024, then gained by 29.24% to $75.1 million in 2025, then retreated by 0.02% to $75.1 million in 2026.
• The last three Total Liabilities figures came in at $75.1 million (Q1 2026), $75.1 million (Q4 2025), and $60.0 million (Q3 2025), per Business Quant data.

Peer Comparison